Pharmaceutical industry export delivery value (half year)
China · as of 30 Jun 2026
Pharmaceutical industry export delivery value in China (half year) stood at 210 billion CNY as of 30 June 2026 (State Council).
- Publisher
- State Council
- Authority tier
- T1 Official
- Locator
- Value of China's innovative drug out-licensing deals hit new high in H1
- Retrieved
- 17 Sep 2026
- Status
- Verified
What the source says
The industry's export delivery value exceeded 210 billion yuan (about 30.91 billion U.S. dollars) in the first six months, up 9 percent from a year earlier.
The figure above was extracted from this passage. If it does not match, the extraction is wrong and we want to know.
Other sources disagree
1 record reports a different value for this same indicator, region and period. We keep both rather than choosing or averaging. The disagreement is itself information.
| Value | Divergence | Source organisation | Document | Locator | Details |
|---|---|---|---|---|---|
| 30.9 billion USD | -85.3% | State Council | Value of China's innovative drug out-licensing deals hit new high in H1 | Value of China's innovative drug out-licensing deals hit new high in H1 | Open record |
Cite this figure
Published under CC BY 4.0. Attribute the original publisher; the citations below do that for you and link to this permanent record.
- APA
- State Council of China. (2026). Value of China's innovative drug out-licensing deals hit new high in H1. Retrieved September 17, 2026, from https://english.www.gov.cn/archive/statistics/202607/20/content_WS6a5de696c6d00ca5f9a0c514.html. Via StatOrigin, https://statorigin.org/stat/stat_3G7S0FFSCZ2AZP77S1QGNWQFFZ
- MLA
- State Council of China. "Value of China's innovative drug out-licensing deals hit new high in H1." 2026, https://english.www.gov.cn/archive/statistics/202607/20/content_WS6a5de696c6d00ca5f9a0c514.html. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_3G7S0FFSCZ2AZP77S1QGNWQFFZ.
- Chicago
- State Council of China. "Value of China's innovative drug out-licensing deals hit new high in H1." 2026. https://english.www.gov.cn/archive/statistics/202607/20/content_WS6a5de696c6d00ca5f9a0c514.html. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_3G7S0FFSCZ2AZP77S1QGNWQFFZ.
- BibTeX
- @misc{statecouncil2026pharmaceuticalnwqffz, author = {{State Council of China}}, title = {Value of China's innovative drug out-licensing deals hit new high in H1}, year = {2026}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_3G7S0FFSCZ2AZP77S1QGNWQFFZ}, note = {Original source: https://english.www.gov.cn/archive/statistics/202607/20/content\_WS6a5de696c6d00ca5f9a0c514.html. Accessed September 17, 2026.} }
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Primary Source
- Publisher
- State Council of China · homepage ↗
- Authority tier
- Tier 1 · Multilateral Official
- Report
- Value of China's innovative drug out-licensing deals hit new high in H1
- Type
- Press release
- Published
- —
- Locator
- Value of China's innovative drug out-licensing deals hit new high in H1
- Retrieved
- 17 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification & Integrity
- Audit status
- Verified
- Review protocol
- Editorial review
- Checked on
- 17 September 2026
- Last revision
- 17 September 2026
- Archival URI
- /stat/stat_3G7S0FFSCZ2AZP77S1QGNWQFFZ